Epilepsy digital Capitalize on SK Life Science’s recent Epilepsy Connect launch to position digital education and clinician engagement services, offering collaboration on continuing medical education, patient support resources, and epilepsy care optimization programs for hospitals and practice networks.

CNS and oncology Leverage their dual focus on CNS disorders and cancer to pursue cross-therapy partnerships, co-development discussions, and supplier relationships with biopharma or contract manufacturers seeking CNS or oncology portfolio expansion.

Strategic partnerships Target SK Life Science’s existing and past partnerships (Angelini Pharma, Axtria collaboration) to propose data-driven commercialization services, market access strategies, and analytics support to accelerate product launches and lifecycle management.

Global affiliation Use SK Group affiliation and rapid expansion potential to propose enterprise-level collaborations, supplier enablement, and shared services opportunities that align with global quality standards and scale strategies.

Clinical leadership Engage through their new leadership appointments in Global Clinical Development and Acting CMO to offer clinical trial optimization, regulatory affairs services, and flexible R&D partnerships to accelerate development timelines.